Category: CovidienSyndicate content

Details of the mega-merger: Covidien makes the 1st move, Almeida prepares to step down

August 6, 2014 by Arezu Sarvestani

Covidien discloses details of the pending $43 billion acquisition by Medtronic, including who approached who and what Covidien chief Jose Almeida will do after handing the reins to Medtronic.

Medtronic and Covidien open up about $43B mega-merger

Congress moves to punish Medtronic and other 'corporate deserters'

August 5, 2014 by Arezu Sarvestani

Democrats in the Senate and House push a measure to withhold federal contracts from companies that move their headquarters overseas to find better corporate tax rates.

Senate moves to punish Medtronic and other 'corporate deserts'

A handful of Democrats in Congress are hoping to curb a corporate exodus by threatening to withhold federal contracts from firms that shift their headquarters overseas to benefit from lower tax rates.

Medtronic, Covidien merger: Ishrak and Almeida go on tour

August 5, 2014 by Arezu Sarvestani

The chiefs of Medtronic and Covidien hit the road to visit a slew of company sites and talk business as the medtech titans prepare to merge.

Ishrak and Almeida go on tour

Medtronic's Omar Ishrak testing devices with with Gene Stellon, R&D VP at Covidien.

Medtech trends: The most talked about device makers in July 2014

August 5, 2014 by Arezu Sarvestani looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.


Click to enlarge. looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

White House rails against Medtronic-style corporate inversions | On Call

August 1, 2014 by Arezu Sarvestani

President Barack Obama condemns corporate inversions, like the one Medtronic's planning in its mega-merger with Covidien, saying that companies are "renouncing their citizenship" in order to dodge taxes. On Call

MASSDEVICE ON CALL — President Barack Obama took time in this weeks' regular address to criticize the wave of "corporate inversions," in which companies, such as Medtronic (NYSE:MDT), are using outside-U.S. acquisitions to shift their headquarters overseas.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

CardioMEMS' 11-year payoff worth the wait for Boston Millennia Partners

July 31, 2014 by Brian Johnson

Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.

The CardioMEMS story didn't end when St. Jude Medical (NYSE:STJ) acquired the Georgia-based company in June, paying $375 million for the stake it didn’t already own, valuing the implantable heart failure monitor company at $463 million total.

Medtronic shareholder sues to block pending merger with Covidien | The week in medtech M&A

July 30, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Report: Medtronic shareholder sues to block Covidien merger; Medtronic pays up to $105 million for Visualase; Elekta eyes Turkish radiology market with acquisition of Mesi Medikal; Ulthera pulls $86M IPO in favor of $600M merger

Report: Medtronic shareholder sues to block Covidien merger

July 24, 2014 by Brad Perriello

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp